Page 120 - JSOM Summer 2023
P. 120

Sepsis-Induced Coagulopathy and
                                  Disseminated Intravascular Coagulation

                                           What We Need to Know and
                                 How to Manage for Prolonged Casualty Care



                                                                       1,2
                       Jason Nam, MD *; An-Kwok Ian Wong, MD, PhD ; David Cantong, NRP ;
                                                                                              3
                                       1
                                                                      5
                    John Alexander Cook, MD ; Zachary Andrews, NRP ; Jerrold H. Levy, MD, FCCM     6
                                              4
          ABSTRACT
          Coagulopathy can occur in trauma, and it can affect septic pa-  and shock. Multiple mediators trigger coagulation.  These
          tients as a host tries to respond to infection. Sometimes, it can   tissue-released mediators cause intense coagulopathy and a
          lead to disseminated intravascular coagulopathy (DIC) with a   hyperinflammatory response.  Tissue factor is a key part of
          high potential for mortality. New research has delineated risk   the extrinsic coagulation pathway; it plays a pivotal role in
          factors that include neutrophil extracellular traps and endo-  coagulopathy and DIC in sepsis.  In addition, these inflam-
                                                                                       3
          thelial glycocalyx shedding. Managing DIC in septic patients   matory mediators activate thrombin as part of a host immuno-
          focuses on first treating the underlying cause of sepsis. Further,   thrombotic response that can exacerbate multiorgan failure in
          the International Society on Thrombolysis and   Haemostasis   sepsis. 4
          (ISTH) has DIC diagnostic criteria.  “Sepsis-induced coagu-
          lopathy” (SIC) is a new category. Therapy of SIC focuses on   Fibrinolysis Shut Down
          treating the underlying infection and the ensuing coagulopa-  The ISTH defines DIC as a global activation of intravascu-
          thy. Most therapeutic approaches to SIC have focused on an-  lar coagulation due to a wide range of causes. Especially in
          ticoagulant therapy. This review will discuss SIC and DIC and   sepsis, fibrinolysis is abnormal and deranged. Plasmin modu-
          how they are relevant to prolonged casualty care (PCC).  lates fibrinolysis. The plasminogen activator system converts
                                                             plasminogen to plasmin. DIC causes endothelial cell injury
          Keywords:  sepsis; disseminated intravascular coagulation;   and dysfunction.  Microcirculatory clots form, and deranged
                                                                          5
          coagulopathy; antithrombin; prolonged casualty care; PCC;   fibrinolysis prevents removal of fibrin and leads to thrombosis
          austere critical care                              throughout the microvascular circulatory system that contrib-
                                                             ute to multiorgan dysfunction. 6
                                                             Endothelial Dysfunction
          Introduction
                                                             Sepsis targets the vascular endothelium, and endothelial injury
          Sepsis activates a coagulation cascade as the host attempts to   leads to a reduced release of prostacyclin and nitric oxide and
          fight off infection. The problem with this response is that it   increased expression of tissue factor and von Willebrand fac-
          can be overwhelming and result in a coagulopathy.  DIC is   tor (vWF).  There is also destruction to the glycocalyx, a thin
                                                                     7
                                                   1
          coagulation gone awry, and not a clinical diagnosis but rather   layer over the vascular endothelium; the glycocalyx also serves
          a response to an underlying condition. Historically, DIC arose   as an important locus of infection and inflammation.  Anti-
                                                                                                        8
          initially from hemorrhagic syndromes of disordered coagula-  thrombin’s antithrombotic activity increases when it binds to
          tion.  The release of several proinflammatory and procoagu-  the glycocalyx. 9,10  During sepsis, components of the glycocalyx
              2
          lant substances following tissue injury in critically-ill septic   are lost, resulting in changes that contribute to microcircula-
          patients or trauma victims causes a type of consumptive coag-  tory dysfunction.
                                                                          11
          ulopathy. We will review sepsis-associated DIC and the newly
          proposed ISTH term—SIC—and how it pertains to providers   Platelet Activation
          doing austere critical care and PCC.               DIC in sepsis often presents with thrombocytopenia (low
                                                             platelet count). Sepsis affects platelet count in a variety of ways
                                                             including increased activation. Despite the increased levels of
          Pathophysiology of SIC and DIC
                                                             thrombopoietin, inflammatory mediators and toxins also sup-
          Coagulation Cascade Turns On                       press the bone marrow’s production of platelets. Thrombin
          In sepsis, the body responds to an infection inappropriately   also activates platelets as well as the complement cascade. All
          and exuberantly, resulting in severe multiorgan dysfunction   these processes work in concert in the pathogenesis of SIC. 12
          *Correspondence to jason.nam@duke.edu
          1 MAJ(P) Jason Nam is a physician affiliated with the Division of Pulmonary, Allergy, and Critical Care Medicine, Duke University Hospital,
                    2
          Durham, NC.  Dr An-Kwok Ian Wong is a physician-scientist affiliated with the Division of Pulmonary, Allergy, and Critical Care Medicine,
          Duke University Hospital, Durham, NC and the Division of Translational Biomedical Informatics, Department of Biostatistics and Bioinfor-
                                                   3
          matics, Duke University School of Medicine, Durham, NC.  SFC David Cantong is an 18D and paramedic affiliated with the 1st Special Forces
          Command (A), Fort Bragg, NC.  CPT John Alexander Cook is a physician and 18D affiliated with the Department of Emergency Medicine,
                                 4
          Duke University Hospital, Durham, NC.  SFC Zachary Andrews is a SOCM and paramedic affiliated with the Defense POW/MIA Accounting
                                       5
                                          6
          Agency, Joint Base Pearl Harbor-Hickam, HI.  Dr Jerrold H. Levy is a physician affiliated with the Department of Anesthesiology, Critical Care,
          and Surgery, Duke University School of Medicine, Durham, NC.
                                                          118
   115   116   117   118   119   120   121   122   123   124   125